Safety of Autologous Stem Cell Treatment for Traumatic Brain Injury in Children

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

October 31, 2009

Conditions
Traumatic Brain Injury
Interventions
DRUG

Autologous bone marrow precursor cell harvest and transplant

Bone marrow harvest (3 ml/kg of body weight) performed between 12 and 30 hours post injury, followed by single intravenous infusion of bone marrow progenitor cells - target dose is 6x10\^6 mononuclear cells/kg body weight, administered within 36 hours of injury

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT00254722 - Safety of Autologous Stem Cell Treatment for Traumatic Brain Injury in Children | Biotech Hunter | Biotech Hunter